Antibodies.com is increasing its UK footprint with a move to Cambridge Technopark to accommodate the company’s rapid growth.
The 5000 sq. ft site is five times larger than its previous premises and has been designed to increase operational capabilities and improve access to its range of reagents and products which support development of new antibody treatments.
Reagents are substances used by researchers to carry out laboratory tests, and Antibodies.com has seen a period of sustained growth and rapid increase in demand for its products globally over the past 5 years.
Its customer base has tripled and now serves over 5.000 research institutions globally. With a catalogue of over 100,000 products, including primary and secondary antibodies, proteins, and ELISA kits, Antibodies.com serves researchers in over 100 countries.
Located on Cambridge Technopark, in Cambridge’s biotech hub, the new site features advanced laboratory spaces, a modern logistics area to facilitate enhanced inventory management, and expanded research and development capabilities.
The upgraded facilities will help boost order fulfilment and speed up deliveries.
Dr Stewart Newlove of Antibodies.com, said: “We are proud to take this significant step forward with our new Cambridge headquarters.
“This move positions us at the centre of the global life sciences community and will enable us to enhance the excellent service our customers have come to expect, scale with global demand, and continue supporting innovation in the discovery and development of antibody therapeutics.”
Antibodies.com has facilities in Cambridge, UK, Stockholm, Sweden, and St. Louis, US.
